abstract |
The compounds of formula (I) and their pharmaceutically acceptable salts can be used in the form of pharmaceutical compositions as HSL inhibitors for the treatment of diabetes: Wherein R 1 , R 2 , R 3 , C a and C b have the meanings set forth in claim 1. |